Showing 581 - 600 results of 1,042 for search '"paediatrics"', query time: 0.04s Refine Results
  1. 581

    Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry by Prasad T. Oommen, Tilmann Kallinich, Juergen Rech, Norbert Blank, Julia Weber-Arden, Jasmin B. Kuemmerle-Deschner

    Published 2024-12-01
    “…Methods From June 2018, the RELIANCE registry enrolled paediatric (aged ≥ 2 years) and adult patients (aged ≥ 18 years) with MKD/HIDS who were receiving canakinumab as part of their routine medical care. …”
    Get full text
    Article
  2. 582

    Epidemiological Changes in Hospitalized Bronchiolitis in Children Under 2 Years of Age in Hangzhou Before and After COVID-19 Restriction Easing by Xu X, Chen X, He J, Su L, Tong X, Sun Y, Huang S, Bai G, Chen Z

    Published 2025-02-01
    “…., Hangzhou, Zhejiang, People’s Republic of China; 2Department of Paediatrics, Cixi Maternity and Child Health Care Hospital, Ningbo, Zhejiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zhimin Chen; Guannan Bai, Email zmchen@zju.edu.cn; guannanbai@zju.edu.cnBackground: Bronchiolitis is a common cause of hospitalization in infants under 2 years of age. …”
    Get full text
    Article
  3. 583
  4. 584
  5. 585
  6. 586
  7. 587
  8. 588
  9. 589
  10. 590
  11. 591
  12. 592

    Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial by Jing Wang, Tao Xu, Miao Liu, Jian Chen, Guang Yang, Weiwei Feng, Yulin Sun, Xiuyu Shi, Liping Zou

    Published 2022-07-01
    “…This study aims to analyse the therapeutic effect of melatonin supplementation for the treatment of IS.Methods and analysis This is a triple-blinded (trial participant, outcome assessor and the data analyst), prospective, randomised controlled trial to be conducted in the Department of Paediatrics, The First Medical Center of Chinese PLA General Hospital, Beijing, China from November 2020. …”
    Get full text
    Article
  13. 593
  14. 594
  15. 595
  16. 596

    Availability and accessibility of cytotoxic medicines in the WHO model list of essential medicines for childhood cancer in low and lower-middle- income countries: a systematic revi... by Maheeka Seneviwickrama, Sashini Shehana Denagamagei, Surangi Jayakody, Sanjeeva Gunasekera, Guwani Liyanage

    Published 2025-01-01
    “…Abstract Background Socio-economic inequalities significantly impact paediatric cancer survival. The review aims to elucidate the facilitators and barriers influencing the availability and accessibility of essential medicines for childhood cancer (EMCC) in low- and lower-middle-income countries (LLMICs). …”
    Get full text
    Article
  17. 597
  18. 598
  19. 599
  20. 600